All filters
Slidesets
Characterization of Hepatitis B Virus (HBV) Among Liver Patients in Kenya- Missiani Ochwoto
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence of HBV and HCV infections in screened people in Rwanda during WHD 2017 campaign- Jean Damascene Makuza
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
17a_Gamal
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Viral hepatitis in paediatrics (B and C)- Manal El-Sayed, MD, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Other special populations (PWID)- John Rwegasha, MBChB, M.MED, FRCP, MSc
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Alcoholic liver disease- Kosh Agarwal, MD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Drug-induced liver disease: khat and other weeds- Asgeir Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Parasitic infections (Schistosomiasis infection, Liver flukes)- Edford Sinkala, BScHB, MBChB, MMed, PhD, FRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Fatty Liver disease- Mark Thursz, MRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Management of Hepatocellular Carcinoma in Africa- Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Management of end-stage Liver Disease in Resource Limited Settings- Mark Sonderup
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
New diagnostics to improve diagnosis of liver disease- Francesco Marinucci
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
NOhep Visionaries in Africa: Medical professionals leading the way towards hepatitis elimination- Jessica Hicks
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Best practice talk; The Netherlands | Marc van der Valk, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
Minimising treatment duration and doses | Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Community and harm reduction response to infection and reinfection | Eberhard Schatz
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Financial models for high- and low income countries | Pieter Walhof
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Role of generic drugs | Andrew Hill, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016